Journals / Journal of Clinical and Analytical Medicine / 2016 / Cilt: 7 - Sayı: 4

Türkiye'deki Aile Hekimlerinin Prostat Hastalarına ve Prostat Spesifik Antijene Yaklaşımları

The Approaches Taken by Family Physicians in Turkey Regarding Prostate Patients and Prostate Specific Antigen

Pages
462–465
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased awareness of approaches to LUTS patients can be provided for family physicians at events such as in-service training and scientific congresses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This survey study questioned family physicians about their approaches to lower urinary tract symptoms (LUTS) and about the clinical application of total and free prostate-specific antigens (tPSA and fPSA).
📊
Key Findings & Data:The survey had 14 questions, none of which identified the respondents, concerning approaches to male patients with LUTS.
💡
Conclusion & Impact:Increased awareness of approaches to LUTS patients can be provided for family physicians at events such as in-service training and scientific congresses.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This survey study questioned family physicians about their approaches to lower urinary tract symptoms (LUTS) and about the clinical application of total and free prostate-specific antigens (tPSA and fPSA). Material and Method: The survey link was prepared online and sent to an email group for family physicians. The survey had 14 questions, none of which identified the respondents, concerning approaches to male patients with LUTS. Some questions were multiple choice and others allowed multiple answers to be chosen. The results were graphed and interpreted. Results: A total of 350 family physicians responded online. While 250 (72%) were family physician assistants or experts, 214 (61%) worked in family health centers. Of the 300 (85%) family physicians who had seen male patients with LUTS, only 64 (20%) stated that they performed a prostate examination. While 298 (99%) of the physicians prescribed alpha blockers, 234 (78%) physicians stated they requested a tPSA, and 134 (44%) answered that they requested an fPSA. Of the 134 physicians, 104 requested an fPSA without regard to the tPSA value. Discussion: The study identified differences in the approaches of family physicians to male patients with LUTS. DRE was not performed for the majority of patients and, as a result, unnecessary requests for fPSA were made. Increased awareness of approaches to LUTS patients can be provided for family physicians at events such as in-service training and scientific congresses.

Özet

Amaç: Bu çalışmada aile hekimlerinin, alt üriner sistem semptomlarına (AÜSS) yaklaşımları, total and serbest prostat spesifik antijen (tPSA ve sPSA) konusundaki klinik uygulamaları sorgulanmıştır. Gereç ve Yöntem: Internet üzerinden çevrimiçi olarak hazırlanan bir anketin linki, aile hekimleri elektronik posta grubuna gönderildi. Toplam 14 sorudan oluşan ankette kimlik bilgilerine yer verilmeyip, AÜSS'u olan erkek hastalara yaklaşımları sorgulandı. Bazı sorular çoktan seçmeli bazıları ise birden fazla seçeneğin işaretlenebileceği türden idi. Sonuçlar grafik haline getirilerek yorumlandı. Bulgular: 350 aile hekimi ankete online olarak yanıt verdi. 250'si (%72) aile hekimi asistanı veya uzmanı olan katılımcıların 214'ü (%61) aile sağlığı merkezlerinde çalışmakta idi. AÜSS'u olan erkek hasta gören 300 (%85) hekimden sadece 64 tanesi (%20) prostat muayenesi yaptığını ifade etti. 298 (%99) hekim alfa blokör ilaç yazarken, 234 hekim (%78) tPSA, 134 (%44) hekim ise sPSA istiyorum cevabını vermiştir. 134 kişinin 104'ü tPSA değerini göz önüne almadan sPSA istemiştir. Tartışma: Aile hekimlerinin AÜSS olan erkeklere yaklaşımları arasında farklılıklar saptanmıştır. DRE'nin çoğu hastaya yapılmadığı ve sPSA'nın lüzumsuz istenmesi gibi sonuçlar ortaya çıkmıştır. Hizmet içi eğitim, bilimsel kongreler gibi etkinlikler ile aile hekimlerinin AÜSS hastalarına yaklaşımlarında farkındalıklarının arttırılması sağlanabilir.

🔖

Cite This Article

RESORLU, B., ULUDAG, A., GULPINAR, M. T., VERİM, L., SANCAK, E. B., AKBAS, A., ERTEKIN, Y. H., TEKİN, M. (2022). Türkiye'deki Aile Hekimlerinin Prostat Hastalarına ve Prostat Spesifik Antijene Yaklaşımları. Journal of Clinical and Analytical Medicine, Cilt: 7 - Sayı: 4, 462–465. https://ajindex.com/articles/560873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Richie JP, Catalona WJ, Ahmann FR, M'Liss AH, Scardino PT, Flanigan RC, de- Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, South- wick PC. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993;42(4):365- 74. Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ. Characteris- tics of prostate cancer detected by digital rectal examination only. Urology 2007;70(6):1117-20.
  2. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL. Early detection of prostate cancer: AUA Guideline. J Urol 2013;190(2):419-26.
  3. Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P. Screening for pros- tate cancer: a guidance statement from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 2013;158(10):761-9.
  4. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A. Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong ENP, Parson RE, Gasior GH, Loveland KG, Soutwick PC. Use of the percentage of free prostate-specific an- tigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998;279(19):1542-7.
  5. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46(4):765-81.
  6. Gosselaar C, Roobol MJ, Roemeling S, Schröder FH. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam. Eur Urol 2008;54(3):581-8.
  7. Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Björk T, Gerdtsson A, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Lilja H. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40- 55 and long term risk of metastasis: case-control study. BMJ 2013; DOI: 10.1136/ bmj.f2023.
  8. Carlsson S, Assel M, Sjoberg D, Ulmert D, Hugosson J, Lilja H, Vickers A. Influ- ence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. BMJ 2014; 348 DOI:10.1136/bmj.g2296.